Insulin in the Adjuvant Breast Cancer Setting: A Novel Therapeutic Target for Lifestyle and Pharmacologic Interventions?
- 20 February 2008
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (6) , 833-834
- https://doi.org/10.1200/jco.2007.14.7132
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Diabetes mellitus and risk of breast cancer: A meta‐analysisInternational Journal of Cancer, 2007
- Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803Journal of Clinical Oncology, 2006
- Metabolic syndrome as a prognostic factor for breast cancer recurrencesInternational Journal of Cancer, 2006
- Targeting insulin-like growth factor pathwaysBritish Journal of Cancer, 2006
- Hormone Replacement Therapy and Decreased Lung Cancer SurvivalJournal of Clinical Oncology, 2006
- Insulin and Hybrid Insulin/IGF Receptors Are Major Regulators of Breast Cancer CellsBreast Disease, 2003
- Weight Loss in Breast Cancer Patient ManagementJournal of Clinical Oncology, 2002
- Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort StudyJournal of Clinical Oncology, 2002
- Insulin and related factors in premenopausal breast cancer riskBreast Cancer Research and Treatment, 1998
- Insulin receptors in breast cancer: Biological and clinical roleJournal of Endocrinological Investigation, 1996